Rocket Lab Reports Strong 2025 Revenue & Record Backlog, Raises $1.1B via ATM, but Neutron Launch Delayed to Q4 2026
summarizeSummary
Rocket Lab reported strong 2025 revenue growth and a record $1.85 billion backlog, bolstered by a major SDA contract and over $1.1 billion raised through ATM offerings, despite increasing net losses and a delay in the Neutron rocket's first launch to Q4 2026.
check_boxKey Events
-
Record 2025 Financial Results
Reported $601.8 million in revenue for 2025, a 38% increase year-over-year, with gross profit improving to $207.2 million (34.4% margin). However, net loss increased to $198.2 million, and cash used in operating activities rose to $165.5 million.
-
Significant Backlog Growth
Total backlog reached $1.847 billion as of December 31, 2025, up from $1.067 billion in 2024. This includes an $816 million contract with the Space Development Agency (SDA) for 18 satellites, with final delivery expected in 2029.
-
Neutron Rocket Launch Delayed
The first launch of the Neutron medium-lift launch vehicle is now targeted for Q4 2026, impacted by an unanticipated Stage 1 tank rupture during qualification testing in January 2026. This follows the 8-K filing on 2026-01-22 which reported the rupture.
-
Substantial Capital Raise through ATM Offerings
Generated $1.146 billion in gross proceeds from At-The-Market (ATM) equity offerings during 2025, significantly increasing cash and cash equivalents to $833.5 million by year-end. This capital raise is highly dilutive.
auto_awesomeAnalysis
This annual report details Rocket Lab's robust financial performance in 2025, marked by significant revenue growth and a record-high backlog, largely fueled by a major $816 million contract with the Space Development Agency. The company successfully secured over $1.1 billion through At-The-Market (ATM) equity offerings, substantially strengthening its cash position to support its capital-intensive development programs. However, the filing also confirms a delay in the crucial Neutron rocket's first launch to Q4 2026 due to a testing setback, and highlights continued net losses and increased cash burn from operations. The substantial equity issuances from both the ATM programs and convertible note conversions will result in significant dilution for shareholders. Investors should consider the strong growth and improved liquidity against the operational challenges and dilutive financing strategy.
At the time of this filing, RKLB was trading at $68.95 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $38.8B. The 52-week trading range was $14.71 to $99.58. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.